Search

Search Results
Results 17671 - 17680 of 17706 for Depression
  • Riamet Dispersible Tablets
    Drug - 22 Jul 2020
    Consumer Medicine Information (CMI) about Riamet Dispersible Tablets (artemether and lumefantrine) intended for persons living in Australia.
  • Ebixa
    Drug - 10 Jun 2020
    Consumer Medicine Information (CMI) about Ebixa (Memantine hydrochloride) intended for persons living in Australia.
  • Minims Atropine Sulphate
    Drug - 1 May 2020
    Consumer Medicine Information (CMI) about Minims Atropine Sulphate (Atropine sulfate monohydrate) intended for persons living in Australia.
  • Lamisil Tablets
    Drug - 13 Feb 2020
    Consumer Medicine Information (CMI) about Lamisil Tablets (terbinafine) intended for persons living in Australia.
  • Minidiab
    Drug - 9 Dec 2019
    Consumer Medicine Information (CMI) about Minidiab (Glipizide) intended for persons living in Australia.
  • Sutent
    Drug - 5 Nov 2019
    Consumer Medicine Information (CMI) about Sutent (Sunitinib malate) intended for persons living in Australia.
  • Micardis® (Telmisartan) Consumer Medicine Information
    Drug - 20 Jun 2019
     
  • Velcade
    Drug - 17 Apr 2019
    Consumer Medicine Information (CMI) about Velcade (Bortezomib) intended for persons living in Australia.
  • Sifrol ER
    Drug - 28 Sep 2018
    Consumer Medicine Information (CMI) about Sifrol ER (pramipexole dihydrochloride monohydrate) intended for persons living in Australia.
  • Minims Prednisolone Sodium Phosphate
    Drug - 14 Sep 2018
    Consumer Medicine Information (CMI) about Minims Prednisolone Sodium Phosphate (Prednisolone Sodium Phosphate Eye Drops) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback